Momelotinib Is Effective in Treatment for <scp>VEXAS</scp> Syndrome: Two Cases Within the <scp>AGMT</scp> Austrian Myeloid Registry
- DOI
- 10.1111/ejh.14445
- Published
- 2025-06-29
- Container
- European Journal of Haematology
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1111/ejh.14445,
title = {Momelotinib Is Effective in Treatment for <scp>VEXAS</scp> Syndrome: Two Cases Within the <scp>AGMT</scp> Austrian Myeloid Registry},
author = {Dominik Kiem and Michael Leisch and Ildiko Toth and Marie‐Christina Mayer and Lisa Pleyer and Richard Greil and Alexander Egle and Thomas Melchardt},
year = {2025},
journal = {European Journal of Haematology},
doi = {10.1111/ejh.14445},
url = {https://doi.org/10.1111/ejh.14445}
}RIS
TY - JOUR TI - Momelotinib Is Effective in Treatment for <scp>VEXAS</scp> Syndrome: Two Cases Within the <scp>AGMT</scp> Austrian Myeloid Registry AU - Dominik Kiem AU - Michael Leisch AU - Ildiko Toth AU - Marie‐Christina Mayer AU - Lisa Pleyer AU - Richard Greil AU - Alexander Egle AU - Thomas Melchardt PY - 2025 JO - European Journal of Haematology DO - 10.1111/ejh.14445 UR - https://doi.org/10.1111/ejh.14445 ER -
APA
Kiem, D., Leisch, M., Toth, I., Mayer, M., Pleyer, L., Greil, R., Egle, A., & Melchardt, T. (2025). Momelotinib Is Effective in Treatment for <scp>VEXAS</scp> Syndrome: Two Cases Within the <scp>AGMT</scp> Austrian Myeloid Registry. European Journal of Haematology. https://doi.org/10.1111/ejh.14445
Source records
- crossref · retrieved 2026-09-27T07:42:03.936Z